Altos Labs

Overview
News
Longevity Tech?
Product stageSegments
Pre-Seed
?
Longevity-focused cell and gene therapy
?

Altos Labs is a biotech company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease, injury, and disabilities to transform medicine. 

Altos Labs involves academics and industry professionals in this common mission.

The company is based in the US in the San Francisco Bay Area and San Diego and in the UK in Cambridge. Altos Labs also reportedly has significant collaborations in Japan.

Leading drug developer Hal Barron, originally from GSK, is the founder and CEO of the company.

Rick Klausner, the former director of the US National Cancer Institute, is the chief scientific officer of Altos Labs, while Hans Bishop, who worked with Klausner on oncology startups, including Grail and Juno Therapeutics, was the president of Altos Labs as of October 2023. 

Funding and financials

The company launched in 2022 with USD 3 billion in capital, fully committed from venture capitalists.

HQ location:
San Francisco CA USA
Founded year:
2021
Employees:
251-500
IPO status:
Private
Total funding:
USD 3.0 bn
Last Funding:
USD 3.0 bn (Series A; Jan 2021)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.